Journal List > J Vet Sci > v.7(4) > 1041682

Lee, Son, and Kim: Attenuation of ischemia-reperfusion injury by ascorbic acid in the canine renal transplantation

Abstract

This study examined the effects of ascorbic acid on the attenuation of an ischemia-reperfusion (I/R) injury after a canine renal transplantation. Eight beagle dogs were subjected to a renal auto-transplantation followed by the administration of ascorbic acid (treatment group) and the same amount of vehicle (physiological saline, control group). Blood samples were collected from these dogs to perform the kidney function tests and the invasive blood pressure was measured in the renal artery at pre- and post- anastomosis. The antioxidant enzymes of level 72 h after the transplant were measured. The kidneys were taken for a histopathology evaluation at day 21. The kidney function tests showed a significant difference between the control and treatment group. The invasive blood pressure in the renal artery was similar in the groups. The activity of the antioxidant enzymes in the blood plasma was significant lower in the control group than in the treatment group. The histopathology findings revealed the treatment group to have less damage than the control group. The results of this study suggest that ascorbic acid alone might play a role in attenuating I/R injury and assist in the recovery of the renal function in a renal transplantation model.

Introduction

Kidney transplantation is the ideal treatment for chronic renal failure and various end-stage renal diseases [4,13,20]. The viability of the transplanted organ depends its ability to tolerate cold and warm ischemia and reperfusion during surgery [6,10]. Ischemia-reperfusion injury is a major cause of renal failure and renal graft rejection. Therefore, reducing the extent of this injury in renal transplant patients is important for achieving a good prognosis.
Renal ischemia-reperfusion (I/R) injury leads to the production of excess reactive oxygen species (ROS) and reactive nitrogen species (RNS). These species cause oxidative stress resulting in alterations in the level of mitochondrial oxidative phosphorylation, ATP depletion, increases in the intracellular calcium and activation of protein kinases, phosphatases, proteases, lipases and nucleases leading to a loss of cellular function and integrity [21]. Therefore, it is important to reduce the levels of these hazardous metabolites in order to improve the patient's outcome.
In order to reduce these metabolites, many studies have examined a variety of free radical oxygen scavengers. These include the effects of external supplementation of antioxidants [3,8,12,13] and the activities of endogenous enzymatic antioxidant defense system in a kidney ischemia/reperfusion injury [2,7]. Ascorbic acid has been used to protect against corneal damage by free radicals in rabbits [19]. In addition, it has also been used to improve the renal hemodynamics as well as decreased oxidative stress, inflammation and fibrosis in the ischemic kidney of pigs [5]. Ascorbic acid is an inexpensive low-priced antioxidant that can be administered easily as it is water-soluble. This study investigated of the ability of ascorbic acid as free radical oxygen scavenger to attenuate ischemia-reperfusion injury and the recovery of the renal function in a canine renal autograft model.

Materials and Methods

Animals and experimental groups

Adult beagle dogs of both genders, weighing 10-13 kg (Marshal Farms, USA) were used in this study. The animals were acclimatized and maintained on a standard diet, a routine lighting cycle and room temperature for 6 months, and had a normal renal function before the surgical procedure. The dogs were assigned randomly into a control group (n = 4) and ascorbic acid treatment group (n = 4).

Kidney harvest

The left kidney was freed from the perirenal tissue and fat, and the left renal artery and vein were then clamped using an atraumatic vascular clamp. The ligation and resection of the vessels was performed at the aorta and caudal vena cava, and moved to a tray filled with ice.

Flushing

After the left kidney had been removed, all the arteries in the control group were perfused with cold normal saline. Cold normal saline and ascorbic acid (100 mg/kg; Dai Han Pharm, Korea) were perfused in the treatment group followed by autotransplantation.

Transplantation

After an overnight fast, the animals are premedicated with atropine sulfate (0.04 mg/kg, SC; Huons, Korea), and an antibiotic prophylaxis with cefazolin sodium (20 mg/kg, IV; Chong Kun Dang, Korea) and an analgesic with meloxicam (0.2 mg/kg, IV; Boehringer Ingelheim, Korea) were administered at induction. The animals were induced with thiopental sodium (12.5 mg/kg, IV; Dai Han Pharm, Korea) and maintained with isoflurane 2% and a 100% oxygen supply during the procedure. All the dogs were administered a balanced electrolyte solution (10 ml/kg/h, IV). The dogs were administered mannitol (1 g/kg, IV; Dai Han Pharm, Korea) 20 min before the nephrectomies. The kidneys were exposed through a midline incision, and the left renal artery, vein, and ureter were mobilized for transplantation. The kidneys were harvested, flushed with a cold, heparinized saline solution, and placed in a cold, sterile saline solution before the anastomosis. The renal vein was anastomosis to the caudal vena cava in an end-to-side manner using a simple continuous suture pattern of 6-0 polypropylene. The renal artery was anastomosed to the external iliac artery in an end-to-end manner using 7-0 polypropylene in a simple interrupted pattern. If 2 renal arteries were present, both arteries were managed with a bridging of the renal arteries using a modification of the technique reported by Sarin et al. [20]. The ureter was sutured to the bladder mucosa in a modified ureteroneocystostomy technique using 5-0 polyglyconate in a simple interrupted pattern. A nephropexy was created by suturing the renal capsule to the abdominal wall with simple interrupted sutures made from 4-0 polyglycolic acid. After implanting the autograft, contralateral kidneys were removed. Postoperatively, all the dogs were allowed access to water and food ad libitum.
Three days after surgery, vitamin C (30 mg/kg) was injected intravenously in treatment group with the same amount of vehicle (physiological saline solution) being injected in the control group.

Renal function

The blood urea nitrogen (BUN) and creatinine levels were determined from the serum samples taken on days 0, 1, 3, 5, and 7 before and after the procedure from the jugular vein, using a commercially available kit (VetTest; IDEXX, Japan). The results are expressed in milligrams per deciliter.

Blood Pressure

The invasive blood pressure was measured using Pulscan-Component (Scionic, USA) and a monitoring-set was used for the arterial blood pressure measurement (B/Braun, Germany) at the renal and external iliac arteries. The blood pressure was measured at pre-anastomosis, 10 and 60 min after the anastomosis through a direct invasion using a 24 G scalp vein set (Korea Vaccine, Korea) in the lumen of the artery.

Antioxidant enzyme activity in plasma

Blood samples were collected using an anticoagulant as EDTA, and centrifuged at 700~1,000 × g for 10 min at 4℃. The samples were then pipetted off the top yellow plasma layer without disturbing the buff layer, and the plasma samples were stored on ice until assayed or were freeze at -80℃. The superoxide dismutase (SOD) activity was determined using a commercial SOD assay kit (Cayman, USA) for measuring the SOD activity from the plasma. The activity was recorded spectrophotometrically at 450 nm. The enzyme activity was calculated as U/ml. The glutathione peroxidase (GSHPx) activity was measured using a commercial GSHPx assay kit (Cayman, USA). The activity was recorded spectrophotometrically at 340 nm. The catalase (CAT) activity was measured spectrophotometrically at 540 nm using a commercial CAT assay kit (Cayman, USA).

Histopathological examination

The study protocol called for euthanizing the surviving canines after the third post-transplant week if the serum creatinine values had normalized to <1.8 mg/dl. The tissue samples from the left kidney were taken for a histology examination after euthanasia on postoperative day 21. The tissue samples were fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned in 4 µm slices, and mounted on slides. After deparaffinizing, each specimen was stained with hematoxylin and eosin for an optical microscopy examination. The morphological characteristics of the kidneys were determined using a blinded histology examination.

Statistical analysis

All the values are expressed as a means ± SD of the determinations for all the dogs in the group. The data was analyzed using an analysis of the variance followed by 2-way repeated measures analysis (ANOVA) and then by a Student's t-test. A p value <0.05 or 0.01 was considered significant.

Results

Renal function

The serum creatinine levels, which are an index of the kidney function, increased significantly to 6.73 ± 2.12 mg/dl in the control group (baseline levels; 0.72 ± 0.07) after 5 days of reperfusion and then decreased gradually. On the other hand, the serum creatinine levels in the treatment group (baseline levels; 0.87 ± 0.06) increased to 2.71 ± 1.32 mg/dl after 3 days reperfusion and then decreased gradually by 7 days. The BUN was also measured as a second index of the kidney function. Similar to the serum creatinine level, the BUN levels in the control group (baseline levels; 11.7 ± 6.68) increased significantly to 176.6 ± 49.32 mg/dl by 5 days after reperfusion. The BUN levels in the treatment group (baseline levels; 14.4 ± 1.26) increased to 59.87 ± 21.04 mg/dl after 7 days reperfusion.

Blood Pressure

The blood pressure was measured directly at the external iliac artery. The systolic blood pressure in the control group increased from 86.5 ± 19.67 to 98.5 ± 11.32 mmHg while in the treatment group, these levels decreased from 86 ± 12.67 to 84.75 ± 15.32 mmHg. In the control group, the diastolic blood pressure also increased from 77.75 ± 18.24 to 88 ± 11.51 mmHg while these levels decreased from 78.5 ± 12.23 to 77 ± 13.83 mmHg in the treatment group. In the control group, the mean blood pressure increased from 80.5 ± 18.92 to 91.75 ± 11.14 mmHg by 60 min after the anastomosis. In contrast, in the treatment group, the mean blood pressure increased to 85.5 ± 15.69 mmHg by 10min and then decreased gradually thereafter, and was almost normalized to 79.5 ± 14.20 mmHg by 60 min. However, there was no significant difference between the groups.

Antioxidant enzyme activity in plasma

The antioxidant enzyme activity in the plasma after the renal autotransplantation was evaluated. The specific SOD, GSHPx and CAT activities before surgery and 72 h after reperfusion are expressed as the mean ± SD. The activity of SOD increased slightly from 2.14 ± 0.22 to 2.31 ± 0.17 nmol/min/ml in the control group. In contrast, the activity of SOD in the treatment group increased from 2.37 ± 0.21 to 2.69 ± 0.25 nmol/min/ml by 72 h of reperfusion (p = 0.037, Fig. 1). There was no significant change in the GSHPx activity in the control group. On the other hand, in the treatment group, the level of activity increased significantly from 109.16 ± 19.51 to 132.47 ± 15.50 nmol/min/ml by 72 h of reperfusion (p = 0.032, Fig. 2). There was no significant change in the CAT activity in the control group whereas the CAT activity in the treatment group increased from 2.73 ± 0.30 to 3.74 ± 0.37 nmol/min/ml by 72 h of reperfusion (p = 0.038, Fig. 3).

Histology and morphologic examination

At the autopsy 21 days after the transplant, the control kidneys in which a normal saline had been administered demonstrated moderate cystic dilation of the tubules along with inflammatory cell infiltration, regeneration of the tubules and congestion (Fig. 4A & B). In contrast, the kidneys in the treatment group, which had been administered ascorbic acid after the renal transplantation showed slight damage to the tubules. The tubular epithelium was essentially normal, even though there was occasional, mild cystic dilation of tubules with mild peritubular inflammatory cell infiltration and regeneration of the tubules (Fig. 4C & D).

Discussion

Oxidative stress is an imbalance between oxidants such as ROS and antioxidants [22], and probably contributes to the development, progression, and complications of both acute renal and chronic renal failure, which is characterized by the increased production or decreased elimination of antioxidants [1,9,15,23,25]. Ascorbic acid reduces the level of reactive oxidant species both intracellularly and extracellularly, and maintains transition metals in their reduced form. In addition, ascorbic acid may quench the free radical intermediates of the carcinogen metabolism. Ascorbic acid is an outstandingly powerful antioxidant that reacts rapidly with a variety of oxidants, including the rather poorly reactive superoxide anion radical [11].
These results suggest that the levels of various antioxidant enzymes (SOD, GSHPx, and CAT) levels, which protect against oxygen free radicals, were higher in the ascorbic acid treated group. Generally, the conversion of the superoxide anion and hydrogen peroxide was impaired due to the decreased levels of SOD, GSHPx and CAT, resulting in an increase in the level of oxygen free radicals [16]. Therefore, the elevated superoxide and hydrogen peroxide levels accelerate the damage to the kidney. However, ascorbic acid as an antioxidant detoxified the hydrogen peroxide produced. In this study, ascorbic acid as an exogenous antioxidant appeared to attenuate I/R injury by increasing the activities of SOD, GSHPx, and CAT. On the other hand, the concentration of antioxidant enzymes increased due to a decrease in their consumption rather than decreased as a result of another scavenger.
In this study, although the invasive blood pressure was similar in both groups, the levels in the treatment group had almost normalized by 60 min after the transplant. There is evidence suggesting that vitamin C may affect the intracellular levels of glutathione, which can improve flow-mediated, endothelium-dependent dilation [29]. Ascorbic acid is a potent aqueous phase antioxidant that has been shown to improve the endothelial dysfunction as a result of an interaction between endothelium-derived NO and ROS [14,26,27]. Although the NO concentration was not measured in this study, it is believed that ascorbic acid can increased the quantity of NO under these conditions.
Bilateral multiple renal arteries were encountered during surgery. According to the literature, approximately 15% of humans have bilateral multiple renal arteries [18]. In this study, 37% of the dogs had double arteries, and all were different sized parallel vessels. Therefore, the technique of bridging the renal arteries was used in this study, and at autopsy, no complications from the arterial stenosis were observed. However, the possibility that multiple renal arteries could have affected the clinical outcomes cannot be excluded. Therefore, a study using more cases as well as a long-term follow-up will be needed.
The histology and morphological examination showed less damage to the tubules in the treatment group than in the control group. It has been reported that an inflammatory response induced by ischemia followed by reperfusion is largely responsible for the tissue damage observed [24,28]. In this study, an inflammatory response demonstrated slight damage to the tubules in the treatment group. Although irreversible damage of tubular system was observed in some dogs in both groups, it is unclear if it was due to surgical problems or to the effects of ascorbic acid. Therefore, further study with more samples will be needed. Although these results cannot explain the entire mechanism for the attenuation of ischemia-reperfusion injury, the results of the functional parameters, histopathological changes, antioxidant enzyme activity suggest that ascorbic acid alone may play a role in attenuating ischemia-reperfusion injury and assist in the recovery of the renal function after a renal transplant.

Figures and Tables

Fig. 1
The total plasma SOD activity after renal auto transplantation followed by 72 h of reperfusion. The values are expressed as the mean ± SD for both groups. *p < 0.05; statistical significances between the control and treatment group.
jvs-7-375-g001
Fig. 2
The plasma GSHPx activity after renal autotransplantation followed by 72 h of reperfusion. The values are expressed as the mean ± SD for both groups. *p < 0.05; statistical significances for control versus treatment group.
jvs-7-375-g002
Fig. 3
The activity of plasma CAT after renal autotransplantation followed by 72 h of reperfusion. The values are expressed as mean ± SD for both groups. *p < 0.05; statistical significances between the control and treatment group.
jvs-7-375-g003
Fig. 4
Microphotographs of the control group (A, B) and ascorbic acid treatment group (C, D). A; Showing partial loss of the lining cells and cystic dilation of the tubules. B; Medullar tubules showed focal apical or loss of apical cytoplasm. C; Showing mild regeneration of the tubular system. D; Tubular system of the medulla showing a normal cellular integrity. H&E stain, A, B, C; ×200, D; ×100.
jvs-7-375-g004

Acknowledgments

This work was supported by Grant No. R11-2002-100-00000-0 from ERC program of the Korea Science and Engineering Foundation.

References

1. Andreoli SP. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol. 1991. 5:733–742.
crossref
2. Barnard ML, Snyder SJ, Engerson TD, Turrens JF. Antioxidant enzyme status of ischemic and postischemic liver and ischemic kidney in rats. Free Radic Biol Med. 1993. 15:227–232.
crossref
3. Bosco PJ, Schweizer RT. Use of oxygen radical scavengers on autografted pig kidneys after warm ischemia and 48-hour perfusion preservation. Arch Surg. 1988. 123:601–604.
crossref
4. Casanova D, Correas M, Moran JL, Salas E, Amado JA, Garcia Unzueta MT, Berrazueta JR. Nitric oxide in cold and warm ischemia reperfusion renal transplantation. Transplant Proc. 2002. 34:45–46.
crossref
5. Chade AR, Rodriguez-Porcel M, Herrmann J, Krier JD, Zhu X, Lerman A, Lerman LO. Beneficial effects of antioxidant vitamins on the stenotic kidney. Hypertension. 2003. 42:605–612.
crossref
6. Cristol JP, Thiemermann C, Mitchell JA, Walder C, Vane JR. Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites. Br J Pharmacol. 1993. 109:188–194.
crossref
7. Dobashi K, Ghosh B, Orak JK, Singh I, Singh AK. Kidney ischemia-reperfusion: modulation of antioxidant defenses. Mol Cell Biochem. 2000. 205:1–11.
8. Gianello P, Saliez A, Bufkens X, Pettinger R, Misseleyn D, Hori S, Malfroy B. EUK-134, a synthetic superoxide dismutase and catalase mimetic, protects rat kidneys from ischemia-reperfusion-induced damage. Transplantation. 1996. 62:1664–1666.
crossref
9. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000. 342:605–612.
crossref
10. Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res. 1992. 26:101–108.
crossref
11. Iheanacho EN, Stocker R, Hunt NH. Redox metabolism of vitamin C in blood of normal and malaria-infected mice. Biochim Biophys Acta. 1993. 1182:15–21.
crossref
12. Lee JI, Kim MJ, Park CS, Kim MC. Influence of ascorbic acid on BUN, creatinine, resitive index in canine renal ischemia-reperfusion injury. J Vet Sci. 2006. 7:79–81.
crossref
13. Mathews KG, Gregory CR. Renal transplants in cats: 66 cases (1987-1996). J Am Vet Med Assoc. 1997. 211:1432–1436.
14. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation. 1999. 100:1161–1168.
crossref
15. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978. 86:271–278.
crossref
16. Miyata T, Kurokawa K, van Ypersele de Strihou C. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int Suppl. 2000. 76:S120–S125.
crossref
17. Mun KC, Bae JH, Suh SI, Kim YH, Lee SH, Kim SP, Kwon TK, Hwang JS. Effect of modified polyhemoglobin on the oxidative damage after ischemia-reperfusion in the liver. Transplant Proc. 2003. 35:126–127.
crossref
18. Pollak R, Prusak BF, Mozes MF. Anatomic abnormalities of cadaver kidneys procured for purposes of transplantation. Am Surg. 1986. 52:233–235.
19. Rubowitz A, Assia EI, Rosner M, Topaz M. Antioxidant protection against corneal damage by free radicals during phacoemulsification. Invest Ophthalmol Vis Sci. 2003. 44:1866–1870.
crossref
20. Sarin PK, Dhanda R, Siwach V, Aggarwal B, Singh B, Kaur R, Jain PK. Bridging of renal arteries: a simple technique for the management of double arteries in living donor renal allograft transplantation. Transplant Proc. 2003. 35:35–36.
crossref
21. Sekhon CS, Sekhon BK, Singh I, Orak JK, Singh AK. Attenuation of renal ischemia/reperfusion injury by a triple drug combination therapy. J Nephrol. 2003. 16:63–74.
22. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997. 82:291–295.
crossref
23. Suzuki K, Ushiyama T, Ishikawa A, Mugiya S, Fujita K. Retroperitoneoscopy assisted live donor nephrectomy: the initial 2 cases. J Urol. 1997. 158:1353–1356.
crossref
24. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest. 1997. 99:2682–2690.
crossref
25. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969. 27:502–522.
crossref
26. Timimi FK, Ting HH, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1998. 31:552–557.
crossref
27. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997. 95:2617–2622.
crossref
28. Vedder NB, Winn RK, Rice CL, Chi EY, Arfors KE, Harlan JM. Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear. Proc Natl Acad Sci USA. 1990. 87:2643–2646.
crossref
29. Vita JA, Frei B, Holbrook M, Gokce N, Leaf C, Keaney JF Jr. L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest. 1998. 101:1408–1414.
crossref
TOOLS
Similar articles